Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $185,417 | 2 | 98.2% |
| Consulting Fee | $2,025 | 1 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,082 | 1 | 0.6% |
| Food and Beverage | $138.32 | 3 | 0.1% |
| Travel and Lodging | $129.40 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Foundation Medicine, Inc. | $185,000 | 1 | $0 (2021) |
| Janssen Research & Development, LLC | $2,025 | 1 | $0 (2021) |
| Celgene Corporation | $1,499 | 2 | $0 (2018) |
| JAZZ PHARMACEUTICALS INC. | $225.78 | 3 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $41.94 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $187,039 | 3 | Foundation Medicine, Inc. ($185,000) |
| 2019 | $212.17 | 2 | JAZZ PHARMACEUTICALS INC. ($212.17) |
| 2018 | $1,082 | 1 | Celgene Corporation ($1,082) |
| 2017 | $458.94 | 2 | Celgene Corporation ($417.00) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2021 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug), DEFITELIO | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/28/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,025.00 | General |
| 04/30/2021 | Foundation Medicine, Inc. | FOUNDATIONONE HEME (Device) | — | In-kind items and services | $185,000.00 | Research |
| Study: FoundationOne Heme-AMC-PRO-20-2059 • Category: ONCOLOGY | ||||||
| 12/03/2019 | JAZZ PHARMACEUTICALS INC. | — | Travel and Lodging | Cash or cash equivalent | $129.40 | General |
| 12/02/2019 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $82.77 | General |
| Category: HEMATOLOGY | ||||||
| 06/13/2018 | Celgene Corporation | Revlimid (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,082.00 | General |
| Category: Hematology / Oncology | ||||||
| 12/09/2017 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $41.94 | General |
| 10/30/2017 | Celgene Corporation | Revlimid (Drug) | — | In-kind items and services | $417.00 | Research |
| Study: CC-5013-AML-002 • Category: Hematology / Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| FoundationOne Heme-AMC-PRO-20-2059 | Foundation Medicine, Inc. | $185,000 | 1 |
| CC-5013-AML-002 | Celgene Corporation | $417.00 | 1 |
About Dr. Todd Cooper, D.O
Dr. Todd Cooper, D.O is a Pediatric Hematology-Oncology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205943701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Cooper, D.O has received a total of $188,792 in payments from pharmaceutical and medical device companies, with $187,039 received in 2021. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "" ($185,417).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Other Specialties Pediatric Hematology-Oncology
- Location Birmingham, AL
- Active Since 08/23/2006
- Last Updated 12/12/2013
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1205943701
Products in Payments
- FOUNDATIONONE HEME (Device) $185,000
- Revlimid (Drug) $1,499
- DEFITELIO (Drug) $82.77
- RYLAZE (Drug) $13.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Birmingham
Julie Kanter Washko, Md, MD
Pediatric Hematology-Oncology — Payments: $358,287
Frederick Goldman, Md, MD
Pediatric Hematology-Oncology — Payments: $123,247
Dr. Jeffrey Lebensburger, Do, DO
Pediatric Hematology-Oncology — Payments: $64,513
Elna Saah, Md, MD
Pediatric Hematology-Oncology — Payments: $26,107
Hope Wilson, Md, MD
Pediatric Hematology-Oncology — Payments: $9,794
Joseph Chewning, M.d, M.D
Pediatric Hematology-Oncology — Payments: $6,081